B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CACNA1C

MOLECULAR TARGET

calcium voltage-gated channel subunit alpha1 C

UniProt: Q13936NCBI Gene: 77524 compounds

CACNA1C (calcium voltage-gated channel subunit alpha1 C) is targeted by 24 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CACNA1C

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Nitrendipine2.4010
2Amlodipine1.795
3Nisoldipine1.795
4Fluoxetine1.393
5Sertraline1.393
6Quinidine1.393
7Arachidonic Acid1.102
8Testosterone1.102
9Fluspirilene1.102
10cbd0.691
11Duloxetine Hydrochloride0.691
12Adapalene0.691
13Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent0.691
14Astemizole Antihistamine drug now withdrawn from0.691
15cannabidiol0.691
16cgp371570.691
17Clotrimazole0.691
18Crizotinib0.691
19Doripenem0.691
20Miconazole0.691
21Reserpine0.691
22Rimonabant0.691
23Troglitazone0.691
24Yohimbine0.691

About CACNA1C as a Drug Target

CACNA1C (calcium voltage-gated channel subunit alpha1 C) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 24 compounds with documented CACNA1C interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CACNA1C inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.